A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1

Neuromuscular Disorders

Volumn 18, Issue 8, 2008, Pages 641-645

  Cardani, R ^a   Mancinelli, E ^a   Saino, G ^a   Bonavina, L ^a   Meola, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Gallbladder; MBNL1; Myotonic dystrophy type 1; Ribonuclear inclusions; Smooth muscle

Indexed keywords

PROTEIN MBLN1; RNA BINDING PROTEIN;

ADULT; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; CHOLELITHIASIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GALLSTONE; HUMAN; IMMUNOFLUORESCENCE; MUSCLE CONTRACTILITY; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; SMOOTH MUSCLE;

ADULT; CHOLELITHIASIS; DESMIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GALLBLADDER DISEASES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCLUSION BODIES; MICROSCOPY, CONFOCAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOTONIC DYSTROPHY; RIBOSOMES; RNA-BINDING PROTEINS;

EID: 48749105274     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.06.366     Document Type: Article

References (28)

1. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69 (1992) 799-808
2. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., and Jansen G. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255 (1992) 1253-1255
3. Harper P.S. Myotonic dystrophy. 3rd ed. (2001), W.B. Saunders, London
4. Nowak T.V., Ionasescu V., and Anuras S. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology 82 (1982) 800-810
5. Bellini M., Biagi S., Stasi C., et al. Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol 28 (2006) 1821-1828
6. Schwindt W.D., Bernhardt L.C., and Peters H.A. Cholelithiasis and associated complications of myotonia dystrophica. Postgrad Med J 46 (1969) 80-83
7. Portincasa P., Di Ciaula A., and vanBerge-Henegouwen G.P. Smooth muscle function and dysfunction in gallbladder disease. Current Gastroenterology Reports 6 (2004) 151-162
8. Taneja K.L., McCurrach M., Schalling M., Housman D., and Singer R.H. Foci of trinucleotide repeat transcripts in the nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128 (1995) 995-1002
9. Ranum L.P.W., and Cooper T.A. RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29 (2006) 259-277
10. Osborne R.J., and Thornton C.A. RNA-dominat diseases. Hum Mol Genet 15 (2006) R162-169
11. Philips A.V., Timchenko L.T., and Cooper T.A. Disruption of splicing regulated by CUG-binding protein in myotonic dystrophy. Science 280 (1998) 737-741
12. Savkur R.S., Philips A.V., and Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29 (2001) 40-47
13. Charlet B.N., Savkur R.S., Singh G., Philips A.V., Grice E.A., and Cooper T.A. Loss of muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10 (2002) 45-53
14. Mankodi A., Takahashi M.P., Jiang H., et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Moll Cell 10 (2002) 35-44
15. Savkur R.S., Philips A.V., Cooper T.A., et al. Insulin receptor splicing alteration in myotonic dystrophy. Am J Hum Genet 74 (2004) 1309-1313
16. Fardaei M., Rogers M.T., Thorpe H.M., et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11 (2002) 805-814
17. Kanadia R.N., Johnstone K.A., Mankodi A., et al. A muscleblind knockout model for myotonic dystrophy. Science 302 (2003) 1978-1980
18. Lam L.T., Pham Y.C., Nguyen T.M., and Morris G.E. Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart. Hum Mol Genet 9 (2000) 2167-2173
19. Artero R., Prokop A., Paricio N., et al. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev Biol 195 (1998) 131-143
20. Miller J.W., Urbinati C.R., Teng-Umnuay P., Stendberg M.G., Byrne B.J., and Thornton C.A. Recruitment of human muscleblind proteins to (CUG) (n) expansions associated with myotonic dystrophy. EMBO J 19 (2000) 4439-4448
21. Cardani R., Mancinelli E., Sansone V., Rotondo G., and Meola G. Biomolecular identification of (CCTG) n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 48 (2004) 437-442
22. Mankodi A., Lin X., Blaxall B.C., Swanson M.S., and Thornton C.A. Nuclear RNA foci in the heart in myotonic dystrophy. Circ Res 97 (2005) 1152-1155
23. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., and Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J 23 (2004) 3103-3112
24. 2+ release in vascular myocytes. J Biol Chem 275 (2000) 9596-9603
25. 2+ signals in cellular signalling. Curr Mol Med 4 (2004) 263-275
26. 2+ sparks in urinary bladder smooth muscle. J Cell Sci 120 (2007) 3784-3791
27. Hotta S., Morimura K., Ohya S., Muraki K., Takeshima H., and Imaizumi Y. Ryanodine receptor type 2 deficiency changes excitation-contraction coupling and membrane potential in urinary bladder smooth muscle. J Physiol 582 (2007) 489-506
28. 2+-ATPase in myotonic dystrophy type 1. Hum Mol Genet 14 (2005) 2189-2200